Boardroom Alpha
Meeting calendar
OSPN · Annual meeting · Friday, June 5, 2026

Onespan Inc

7 nominees · 5 ballot items.

Election of seven directors; advisory approval of named executive officer compensation; advisory vote on frequency of future say-on-pay votes (one year); approve amendment to increase shares under 2019 Omnibus Incentive Plan by 2,000,000; ratify appointment of KPMG LLP as independent registered public accounting firm for fiscal 2026.

Market cap
$574M
1Y TSR
-5.0%
Board grade
C
Record date
Apr 8, 2026
Filing
DEF 14A
Meeting concluded · Jun 5, 2026

Follow how the vote landed and what changed on Onespan Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot5

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect seven directors named in the proxy statement to serve until the 2027 annual meeting.

  2. 2

    Advisory Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory approval of the named executive officer compensation as disclosed in the proxy statement for 2025.

  3. 3

    Advisory Vote on Frequency of Future Advisory Votes on Executive Compensation (Say-on-Pay Frequency

    ManagementBoard: FOR

    Non-binding advisory vote on whether future advisory votes on named executive officer compensation should occur every one, two, or three years; Board recommends ONE YEAR.

  4. 4

    Approval of Stock Plan Amendment

    ManagementBoard: FOR

    Approve amendment to Amended and Restated 2019 Omnibus Incentive Plan to increase available shares by 2,000,000.

    More detail

    Proposal 4 asks shareholders to approve a 2,000,000-share increase to the authorized pool under OneSpan’s 2019 Omnibus Incentive Plan. Management argues the increase is necessary to maintain competitive equity grant capacity given recent hires and acquisitions (Nok Nok Labs and Build38) and that lower stock prices have increased share burn. The amendment does not change plan governance terms or add an evergreen feature; it preserves anti-dilution adjustments, a minimum one-year vesting, no repricing without shareholder approval, limits on non-employee director awards, and committee administration by independent directors. Management shows overhang and burn rate metrics and asserts the requested increase would represent roughly 5.4% of outstanding shares as of April 8, 2026 and expects grants to last 1–3 years; they caution that failure to approve may require higher cash compensation or impair hiring/retention. The Board recommends FOR, noting the amendment’s features intended to protect shareholders (no repricing, no automatic vesting on change in control, no evergreen, limited liberal recycling). The Committee reviewed peer burn-rate benchmarks and concluded the increase is judicious and consistent with governance best practices. Vote FOR is recommended to preserve equity-based pay competitiveness and alignment with stockholder interests.

  5. 5

    Ratification of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify appointment of KPMG LLP as the company’s independent registered public accounting firm for fiscal year 2026 (advisory, non-binding).

Director elections

Nominees on the ballot7

Independent
Tenure on this board
7.1 yrs
Also a director at
Asana Inc (ASAN)
Independent
Tenure on this board
5.1 yrs
Also a director at
Powerfleet Inc (AIOT)Sps Commerce Inc (SPSC)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.5.6%2,077,662$22M
2Legal General Group Plc5.3%1,967,954$21M
3Neuberger Berman Group LLC4.4%1,629,976$17M
4VANGUARD CAPITAL MANAGEMENT LLC4.3%1,606,479$17M
5DIMENSIONAL FUND ADVISORS LP3.7%1,389,720$15M
6VANGUARD PORTFOLIO MANAGEMENT LLC3.7%1,371,050$14M
7STATE STREET CORP3.6%1,328,604$14M
8ARROWSTREET CAPITAL, LIMITED PARTNERSHIP3.4%1,268,242$13M
9MILLENNIUM MANAGEMENT LLC2.7%1,009,376$11M
10BlackRock, Inc.2.7%1,001,864$11M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Onespan Inc 2026 annual meeting?
Onespan Inc (OSPN) holds its 2026 annual shareholder meeting on Friday, June 5, 2026.
What is the record date for the Onespan Inc 2026 meeting?
The record date for the Onespan Inc 2026 meeting is Wednesday, April 8, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Onespan Inc's 2026 meeting?
The board is presenting 7 director nominees at the Onespan Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Onespan Inc 2026 meeting?
Shareholders will vote on 5 proposals at the Onespan Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer